✦ LIBER ✦

Colorectal cancer in inflammatory bowel disease

✍ Scribed by Raoul Mayer; W. Douglas Wong; David A. Rothenberger; Stanley M. Goldberg; Robert D. Madoff

Publisher: Springer
Year: 1999
Tongue: English
Weight: 603 KB
Volume: 42
Category: Article
ISSN: 0012-3706
DOI: 10.1007/bf02236351

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoprophylaxis of colorectal cancer in

Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: Current concepts

✍ Jonathan S. Levine; Robert Burakoff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review exa

Two distinct groups of colorectal cancer

Two distinct groups of colorectal cancer in inflammatory bowel disease

✍ Stephan Brackmann; Solveig Norheim Andersen; Geir Aamodt; Borghild Roald; Frøydi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

## Background: The histological variability in colitis-associated colorectal cancer (crc in inflammatory bowel disease [ibd]) and the association to clinical factors is unknown. ## Methods: In population-based material including 67 patients with crc in ibd, histopathology of the cancers and tissu

Differential MicroRNA expression tracks

Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer

✍ Ziad Kanaan; Shesh N. Rai; M. Robert Eichenberger; Christopher Barnes; Amy M. Dw 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 1 views

## One of the most serious complications faced by patients with inflammatory bowel disease (IBD) is the potential development of colorectal cancer (CRC). There is a compelling need to enhance the accuracy of cancer screening of IBD patients. MicroRNAs (miRNAs) are small nonprotein-coding RNAs that

Proinflammatory cytokines and IL-10 in i

Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients

✍ Andrzej Szkaradkiewicz; Ryszard Marciniak; Izabela Chudzicka-Strugała; Agnieszka 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 158 KB

Widespread but not localized neoplasia i

Widespread but not localized neoplasia in inflammatory bowel disease worsens the prognosis of colorectal cancer

✍ Stephan Brackmann; Geir Aamodt; Solveig Norheim Andersen; Borghild Roald; Frøydi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Background: Patients with inflammatory bowel disease (ibd) are at increased risk of colorectal cancer (crc). recently, new phenotypes of crc in ibd have been suggested. studies of the prognosis of crc in ibd have shown conflicting results. the aim of the study was to analyze factors for prognosi

Immunohistochemical expression of CDX2,

Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer

✍ Camille Laurent; Magali Svrcek; Jean-François Flejou; Marie-Pierre Chenard; Bern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

Background: Inflammatory bowel disease (IBD) exposes patients to an increased risk of colorectal cancer (i-CRC) and differences between i-CRC and sporadic colorectal cancer (s-CRC) pathogenesis were reported. In s-CRC, studies indicate abnormalities in the tumor-suppressor gene Cdx2. This study comp